Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2016 | Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer | Chiang N.-J.; CHIUN HSU ; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Huang S.-F.; Chen L.-T. | Scientific Reports | 18 | 15 | |
2013 | Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort | Wang S.-C.; Ho I.-K.; Tsou H.-H.; Liu S.-W.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Liu S.C.; Wu H.-Y.; Kuo H.-W.; Chen A.C.H.; Chang Y.-S.; Liu Y.-L. | OMICS A Journal of Integrative Biology | 39 | 32 | |
2017 | Integrated care for geriatric frailty and sarcopenia: a randomized control trial | DING-CHENG CHAN ; Tsou H.-H.; CHIRN-BIN CHANG ; RONG-SEN YANG ; JAU-YIH TSAUO ; Chen C.-Y.; Hsiao C.-F.; Hsu Y.-T.; Chen C.-H.; Chang S.-F.; Hsiung C.A.; Kuo K.N. | Journal of Cachexia, Sarcopenia and Muscle | 50 | 49 | |
2020 | Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study | Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG ; CHIUN HSU ; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. | Liver International | 6 | 5 | |
2021 | Nonpolio enterovirus activity during the COVID-19 Pandemic, Taiwan, 2020 | Kuo S.-C.; Tsou H.-H.; Wu H.-Y.; Hsu Y.-T.; Lee F.-J.; Shih S.-M.; Hsiung C.A.; WEI J. CHEN | Emerging Infectious Diseases | 11 | 10 | |
2012 | A pilot randomized controlled trial to improve geriatric frailty | DING-CHENG CHAN ; Tsou H.-H.; RONG-SEN YANG ; JAU-YIH TSAUO ; Chen C.-Y.; Hsiung C.A.; Kuo K.N. | BMC Geriatrics | 110 | 101 | |
2012 | UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients | Tian J.-N.; Ho I.-K.; Tsou H.-H.; Fang C.-P.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Chen Y.-T.; Liu S.C.; Hsu Y.-T.; Kuo H.-W.; Liu C.T.; Yang Y.-T.; Chen A.C.H.; Shih Y.-H.; Liu Y.-L. | Pharmacogenomics | 32 | 26 |